TTA Advised Quadria Capital In Acquisition Of Minority Shareholding In Aragen Life Sciences
TTA Advised Quadria Capital In Acquisition Of Minority Shareholding In Aragen Life Sciences
Talwar Thakore & Associates (TT&A) advised Quadria Capital in its acquisition of minority shareholding in Aragen Life Sciences Limited through a combination of primary and secondary investment for USD 100 million. This funding will support Aragen’s strategic expansion of its capabilities and infrastructure, enabling Aragen to meet the growing demand for outsourcing services from innovators in the US and Europe. With this investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen and this partnership solidifies Aragen’s reputation for delivering high-quality “concept to clinic” and “concept to commercial” services to its global customer base comprising all sectors of health – Human, Animal and Plant.
TT&A Team comprised Joint Managing Partner Gautam Saha; Partner Amrita Patnaik; Managing Associates Ambika Sahai & Garvita Mehrotra and Senior Associate Aditi Somani.
Source: TTA’s LinkedIn Page
